Business Seminar
Speaker: Toshiharu Ohba (TAKARA BIO INC.)
http://www.takara-bio.com
Takara Bio supports biotechnology research worldwide.
Dr. Ohba has been engaged in the marketing.
He had experienced many researches, including collaborative project with academia and government.
Besides, he also worked on contract research business.
Date&Time: 11 Oct. (FRI.) 2013 13:15- 14:45
Venue: Lecture room3 (4F), Medical Education & Library Building
Title: Selling Biotechnology
Summary:
Since its 1979 introduction of the first domestically produced restriction enzymes - essential components of genetic engineering research - Takara Bio Inc. has been at the forefront of biotechnology in Japan. The company has continued to market a broad spectrum of advanced biotechnologies, ranging from the polymerase chain reaction (PCR) method to next-generation sequencing (NGS) technologies, through the distribution of reagents and scientific instruments and contract research services not only in Japan and Asia, but all across the globe.
In this lecture, a brief sketch of NGS technology and its latest trends will be introduced and the present state and future potential of human genome analysis using the NGS technology will be discussed. I will also speak from my own experience to stress the importance of having multifaceted expertise and conclude the session with a case study of the human resources required by a company selling biotechnology, in the hopes of offering for consideration a profile of the kind of workers sought by enterprises.
